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Abstract
Alpha thalassemia has not been systematically investigated in Brazil. In this study, 493 unrelated individuals from the
southernmost Brazilian state of Rio Grande do Sul were screened for deletional forms of -thalassemia. One hun-
dred and one individuals had microcytic anemia (MCV < 80 fL) and a normal hemoglobin pattern (Hb A2 < 3.5% and
Hb F < 1%). The subjects were screened for -
3.7,- 
4.2,- 
20.5,—
SEA and —
MED deletions but only the -
3.7 allele was de-
tected. The -
3.7 allele frequency in Brazilians of European and African ancestry was 0.02 and 0.12, respectively,
whereas in individuals with microcytosis the frequency was 0.20. The prevalence of -thalassemia was significantly
higher in individuals with microcytosis than in healthy individuals (p = 0.001), regardless of their ethnic origin. There
were also significant differences in the hematological parameters of individuals with -
3.7/,- 
3.7/-
3.7 and -thalas-
semia trait compared to healthy subjects. These data suggest that -thalassemia is an important cause of
microcytosis and mild anemia in Brazilians.
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The thalassemias are a diverse group of microcytic
hemolytic anemias characterized by defective synthesis of
the  or  globin chain that results in -thalassemia and
-thalassemia, respectively (Kazazian, 1990). The molecu-
lar lesions associated with -thalassemia can be classified
as 
+ or 
0 defects, depending on whether they partially or
completelyabolish-globinchainproduction,respectively
(Higgs and Weatherall, 2009).
The spectrum of mutations that underlie -thalas-
semias varies considerably among different populations.
This finding suggests that these mutations almost certainly
aroselocallyandthattheirfrequencyhasexpandedthrough
a combination of natural selection, founder effect and gene
drift.Thereisstrongevidencethatnaturalselectionreflects
past or present exposure to malaria. Overall, the -thalas-
semias follow a similar distribution to the -thalassemias,
extending from sub-Saharan Africa through the Mediterra-
nean region and Middle East, to the Indian sub-continent
and East and South-East Asia (for a review see Higgs and
Weatherall,2009).Themostcommon
+-thalassemiadele-
tionalallelesare-
3.7and-
4.2.The-
3.7allelehasbeenob-
servedworldwide,withhigherfrequenciesinsomeAfrican
and Mediterranean populations. The -
4.2 is most common
in Asian countries although it also occurs in Mediterranean
populations (Flint et al., 1993). The -
20.5 and —
Med alleles
arealsofrequentamongMediterraneanpopulations(Katta-
mis et al., 1996). Non-deletional -thalassemias are gener-
ally less frequent and have limited geographical distribu-
tions when compared to the deletional forms of the disease
(Higgs and Weatherall, 2009).
The current Brazilian population was formed by suc-
cessive migratory waves. Amerindians already occupied
BrazilianterritorywhenthePortuguesearrivedin1500and
colonized the country. From the 16
th to 19
th centuries Afri-
cans were brought to Brazil as slaves, with other migratory
wavesofEuropeansoccurringinthe19
thand20
thcenturies,
mainly from Italy, Germany and Spain (Salzano and Bor-
tolini, 2002). All of these migratory events have contrib-
uted to the formation of a highly admixed multiethnic
population. This heterogeneity has been documented in
several genetic studies using uniparental or autosomal
markers that revealed a typical, non-uniform triethnic (Eu-
ropean+African+Amerindian) pattern for the Brazilian
population gene pool. Southern populations generally have
lower African and higher European contributions when
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Short Communicationcompared to other Brazilian groups (Salzano and Bortolini,
2002; Callegari-Jacques et al., 2003; Parra et al., 2003;
Zembrzuski et al., 2006; Leite et al., 2008, 2009). The mi-
gration of people mainly from sub-Saharan Africa and the
Mediterranean region introduced thalassemias into the pre-
sent-day Brazilian population since there is no evidence for
autochthonous thalassemias in Brazilian Amerindians
(Zago et al., 1995).
Although several investigations have reported the
prevalence of hemoglobin disorders in Brazil, -thalas-
semia in particular has not been systematically investi-
gated. Few studies have screened Brazilians to estimate the
prevalence of -thalassemia in the general population. So-
nati et al. (1991) observed a prevalence of 21% heterozy-
gous -
3.7/ and 2% homozygous -
3.7/-
3.7 genotypes in
African Brazilian blood donors from the southeast. In an-
other survey in a highly admixed northeastern population
the -
3.7/ genotype was detected in 20% of 514 newborn
babieswhilethehomozygousgenotypewasseenin2.5%of
the children investigated (Adorno et al., 2005). In a recent
study, the frequency of the -
3.7/ genotype in a healthy
admixed northern Brazilian population was 7% (Souza et
al., 2009). The present study was done to determine the
prevalence of -thalassemia in southern Brazilians of Afri-
can and European ancestry and in a sample of patients with
mild anemia, microcytosis and normal iron status from the
same population.
493 unrelated individuals were enrolled in this study.
The largest sample consisted of 392 volunteers (191 Afri-
canBraziliansand201BraziliansofEuropeanancestry)re-
cruited randomly during free routine laboratory blood
determinations in the School of Pharmacy at the Federal
University of Rio Grande do Sul (UFRGS); the subjects
had been sent for these determinations by city health cen-
ters. The blood samples were collected in 2001 and 2002.
The remaining 101 subjects were recruited from individu-
alsreferredtotheHemoglobinCenterofthesameSchoolto
investigate microcytosis with no iron deficiency, chronic
condition or intestinal parasitic worms. This study was ap-
proved by the Ethics Committee at UFRGS, and all of the
participantsprovidedwritteninformedconsentpriortopar-
ticipating in the study.
The blood samples were collected in vacuum tubes
with EDTA as anticoagulant. The hematological indices
wereobtainedwithanautomatedcounter(ABXMicros60,
Horiba Group, Japan). For those subjects referred to the
Center because of microcytosis (MCV < 80 fL), the inclu-
sion criterion was a previous diagnosis compatible with the
possible presence of -thalassemia based on a normal Hb
profile evaluated by high-performance liquid chromatogra-
phy (HPLC; Bio-Rad Variant-Beta-Thal Short Program)
and/or isoelectric focusing (IEF; Perkin-Elmer). All of the
subjects had Hb A2 < 3.5% and Hb F < 1%. All of the pa-
tients had a normal iron status and/or a clinical suspicion of
-thalassemia (no response to iron therapy).
Genomic DNA was obtained from peripheral blood
by a salting-out procedure (Lahiri and Nurnberger, 1991).
The -globin genotypes were screened with the polymer-
ase chain reaction (PCR) in multiplex reactions as de-
scribed by Tan et al. (2001) or in single reactions with the
primers and protocols described by Dode et al. (1993). The
genotypes were determined after electrophoresis of the
amplicons in 1% agarose gels containing ethidium bro-
mide. A 100 bp ladder was used to score the band sizes and
a known heterozygous sample was run as a positive control
in all gels.
The genotypic distribution and allele frequencies
were estimated by gene counting. Deviation from Hardy-
Weinberg equilibrium was tested by the chi-square test.
The genotypic and allele frequencies among groups were
compared using the chi-square test or, when appropriate,
Fisher’s exact test. All statistical comparisons were done
using the WinPEPI program (Abramson, 2004) with a va-
lue of p < 0.05 indicating significance.
Hemoglobin (Hb), hematocrit (Hct) and red blood
cell (RBC) values were corrected for age and sex. Multi-
variate Analysis of Variance (MANOVA) was used to
compare these adjusted variables, as well as the mean cor-
puscular volume (MCV), mean corpuscular hemoglobin
(MCH) and mean corpuscular hemoglobin concentration
(MCHC), with the corresponding values in patients with
microcytic anemia (several -genotypes), in a previously
characterizedgroupof124-thalassemiatraitcarriersfrom
the same population (Reichert et al., 2008) and in healthy
(control) volunteers. The SNK procedure was used for sub-
sequent pairwise multiple comparisons between groups,
except for RBCs, for which Tamhanes test was used to ac-
count for heterocedasticity. These tests were done using
SPSS v12.0.
The allele and genotypic frequencies for the various
groups are shown in Table 1. All of the patients with
microcytosiswerescreenedfor-
3.7,-
4.2,-
20.5,—
SEAand
—
MEDdeletionsbutonlythe-
3.7allelewasdetected.Since
thisallelewastheonlyoneobservedinmicrocyticpatients,
the investigation in volunteers was also restricted to the
-
3.7 deletion. Among 201 Euro-descendents, 9 (4.5%)
wereheterozygousfor-
3.7/,whereas44(23.1%)of191
African Brazilians had -thalassemia: 41 (21.5%) were
heterozygous (-
3.7/) and 3 (1.6%) were homozygous
(-
3.7/-
3.7) for the -
3.7 deletion genotype. Among 101
subjects with mild anemia and microcytosis, 32 (31.7%)
had-thalassemia,ofwhich23(22.8%)wereheterozygous
for the -
3.7 deletion and 9 (8.9%) were homozygous
(-
3.7/-
3.7). The -
3.7 allele frequency observed was 0.02,
0.12 and 0.20 for Euro and African Brazilians and patients
with microcytic anemia, respectively. The frequency of
-thalassemia in patients with microcytic anemia was sig-
642 Wagner et al.nificantly higher than in healthy volunteers, regardless of
their ethnic origin (p = 0.001).
The blood parameters in individuals with -thalas-
semia genotypes, -thalassemia trait and volunteers are
shown in Table 2. All of the volunteers had an MCV of
81.2-103.6 fL. MANOVA revealed significant differences
in the hematological parameters of the various groups
(-
3.7/,- 
3.7/-
3.7, -thalassemia trait and volunteers)
(Pillai’s trace for comparison between genotypes:
F=38,58;p<0.001).Subsequentunivariateanalysesofthe
values for Hb, Hct and MCHC clearly separated the volun-
teers from patients, but there was no difference among the
various groups of patients. On the other hand, MCV and
MCH discriminated among the four groups of individuals
and there was a trend from high values in volunteers to low
values in -thalassemia trait patients, with intermediate
values for -
3.7/ and -
3.7/-
3.7. Healthy volunteers and
-
3.7/ subjects had similar RBC numbers (4.6 x 10
12/L)
thatweresignificantlylowerthanin-thalassemiatraitcar-
riers; individuals with -
3.7/-
3.7 had an intermediate num-
ber of RBCs that was not significantly different from the
other groups.
Microcytic hypochromic anemia is a common hema-
tological condition in clinical practice. As shown here,
-thalassemia, represented by the -
3.7 deletion, is a com-
mon cause of this hematological alteration (present in
31.7% of microcytic patients). These results agree with
those reported by Borges et al. (2001) for a southeastern
Brazilian population in which -thalassemia explained
about 50% of the cases with microcytosis. Other studies
that have used an approach similar to that described here
have reported -thalassemia in 25%-80% of microcytosis
patients in European or European-derived populations (Fo-
glietta et al., 1996; Sivera et al., 1997; Bergeron et al.,
2005; Di Bella et al., 2006; Lafferty et al., 2007).
This is the first report of the prevalence of -thalas-
semia in the general Brazilian population of European an-
cestry. The -
3.7 allele frequency observed here was 0.02,
which is similar to that observed in Portuguese (3.5%)
(Peres et al., 1995) and Italians (5%) (Velati et al., 1986)
with whom southern Brazilians of European descent share
common ancestors, but was significantly (p = 0.001) lower
than in African Brazilians (Table 1). In the latter group,
-thalassemia genotypes were present in 23.1% of the pop-
ulation,withanallelefrequencyof0.12.Asexpectedinad-
mixed populations such as the African Brazilians investi-
gated here, this allele frequency was somewhat lower than
in African populations, where the frequency of -
3.7 -tha-
lassemia ranges from 16.8% in Guinea-Bissau (Masmas et
al., 2006) to 24% in Senegal (Migot-Nabias et al., 2006).
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Table 1 - 
3.7 allele and genotype frequencies.
Allelic frequencies Genotypes
Subjects  -
3.7 / -
3.7/ -
3.7/-
3.7
Euro-descendants 0.98 0.02 192 (95.5)* 9 (4.5) 0
African Brazilians 0.88 0.12 147 (77.0) 41 (21.5) 3 (1.6)
p < 0.001 < 0.001 < 0.001
Patients with microcytic anemia 0.80 0.20 69 (68.3) 23 (22.8) 9 (8.9)
p
§ < 0.001 < 0.001 < 0.001 < 0.001 0.027
p
# < 0.001 < 0.001 0.01 < 0.001
*Number of individuals and percentage (in parentheses).
§,#compared with Euro-descendants and African Brazilians, respectively.
Table 2 - Blood indices in -thalassemia genotypes, -thalassemia trait and healthy individuals.
Blood index Subjects p
-
3.7/ -
3.7/-
3.7 -thalassemia Healthy
Hb (g/dL)* 11.5  0.23
a 11.3  0.16
a 11.2  0.13
a 14.1  0.12
b < 0.001
RBC (x 10
12/L)* 4.65  0.12
a 5.00  0.17
a, b 5.47  0.06
b 4.66  0.04
a < 0.001
Hct (%)* 35.8  0.70
a 35.8  0.58
a 35.4  0.39
a 42.5  0.33
b < 0.001
MCV (fL) 77.3  1.35
a 71.6  1.77
b 67.0  1.44
c 91.3  0.38
d < 0.001
MCH (pg) 24.9  0.47
a 22.6  0.73
b 21.4  0.57
c 30.2  0.14
d < 0.001
MCHC (%) 31.9  0.23
a 31.6  0.35
a 31.9  0.38
a 33.1  0.76
b < 0.001
The values are the mean  SEM. Hb: hemoglobin, RBC: red blood cell, Hct: hematocrit, MCV: mean corpuscular volume, MCH: mean corpuscular he-
moglobin,andMCHC:meancorpuscularhemoglobinconcentration.MeansidentifiedbythesamelettersdidnotdiffersignificantlybytheSNKtest,ex-
cept for RBC, for which the Tamhane test was used. *Analyzed using values corrected for age and sex.The frequency of the -
3.7 allele in this study was similar to
thatofthreeoutoffourBrazilianpopulationsofAfricanan-
cestryinvestigatedbyothers(Sonatietal.,1991;Adornoet
al., 2005), despite different degrees of African admixture,
and much higher than the prevalence described in northern
Brazil (7%) where Amerindian admixture is higher than
African admixture (Souza et al., 2009).
Among patients with mild anemia and microcytosis
that remained undiagnosed, it is possible that the non-
deletional forms of -thalassemia determined by the -
Hph
and -
NcoI alleles, which are common in Mediterranean
populations(Fogliettaetal.,1996;Kattamisetal.,1996;Di
Bella et al., 2006), could explain a proportion of these
cases, mainly among those of European ancestry. In addi-
tion, rare deletional forms not included in the PCR multi-
plex reaction could also be present in some patients.
As shown in Table 2, the values for various blood pa-
rameters were significantly different among healthy volun-
teers and individuals with -thalassemia genotypes and the
-thalassemia trait. In contrast to ß -thalassemia carriers,
for which important regional differences in the mutational
profile have been identified in Brazilian populations (Rei-
chert et al., 2008), -thalassemias show considerably less
variability, which greatly facilitates the implantation of ad-
equate public health policies and diagnostic services for
dealing with this frequent genetic trait and for diagnosing
microcytosis. In this context, the data reported here may
serve as potential reference values for the detection of Bra-
zilian patients suspected of having thalassemia. Finally, in
individuals with microcytosis that is unrelated to an iron
deficiency or an inflammatory state, the identification of
-thalassemia can avoid the need for expensive investiga-
tions to define the etiology of the anemia and eliminate un-
necessary iron supplementation.
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